Sarissa: Add Schlesinger to Alkermes board and ‘withhold’ Richard Gaynor

Sarissa said in part: “We urge our fellow Alkermes shareholders to vote the BLUE universal proxy card “FOR” Sarah Schlesinger to provide much needed oversight and accountability at Alkermes and vote “WITHHOLD” on Richard Gaynor, a cancer specialist whose skills will be unnecessary after the spin of the cancer business in a few months.” “Shareholders face an important decision at the upcoming Alkermes annual shareholder meeting. We need to send a strong message to Chairman and CEO Pops that we will not accept a reversion to the status quo of prolonged underperformance.”